Bayer CropScience AG and Precision BioSciences Collaborate to Create Site-Specific Genome Modifications in Plants

MONHEIM, Germany--(BUSINESS WIRE)--Bayer CropScience and Precision BioSciences Inc., a biotechnology company headquartered in Research Triangle Park, NC, USA, announced today that they have entered into a collaborative agreement to create site-specific genome modifications in plants. The agreement provides Bayer CropScience with non-exclusive access to aspects of Precision BioSciences’ proprietary Directed Nuclease Editor™ (DNE) technology, which can be used to develop novel traits in plants.